Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Marko Lagančić"'
Autor:
Marko Lagančić, Srećko Budi
Publikováno v:
Liječnički vjesnik, Vol 144, Iss 7-8, Pp 254-265 (2022)
Anaplastic large cell lymphoma (ALCL) is a rare subtype of non-Hodgkin lymphoma (NHL) and it originates from mature T lymphocytes. Its subtypes are primary cutaneous ALCL (PC-ALCL), two subtypes of systemic ALCL (ALK-positive and ALK-negative), and b
Externí odkaz:
https://doaj.org/article/b2e897f217814caf95309b68bda4be70
Autor:
Marko Lucijanić, Josip Stojić, Armin Atić, Tomislav Čikara, Besa Osmani, Mislav Barišić-Jaman, Ana Andrilović, Petra Bistrović, Anamarija Zrilić Vrkljan, Marko Lagančić, Marko Milošević, Ivan Vukoja, Lovorka Đerek, Tomo Lucijanić, Nevenka Piskač Živković
Publikováno v:
Wiener klinische Wochenschrift. 134:377-384
C‑reactive protein (CRP) and albumin are inflammation sensitive parameters that are regulated by interleukin‑6 inflammatory pathways. The CRP to albumin ratio (CAR) integrates these two into a potent clinical parameter whose clinical and prognost
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b3208becc1ae663bc2c97540d6a5fc8
https://doi.org/10.1007/s00508-021-01999-5
https://doi.org/10.1007/s00508-021-01999-5
Publikováno v:
Zeitschrift fur Geburtshilfe und Neonatologie. 226(5)
Cell-free DNA (cfDNA) first-trimester screening for fetal aneuploidies, as a non-invasive, safe, and rather accurate method, has changed prenatal screening policies all over the world. Owing to aggressive marketing, cfDNA screening tests exhibit glob
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17d458e92b77f6153ca9c86d901b1165
https://pubmed.ncbi.nlm.nih.gov/36037825
https://pubmed.ncbi.nlm.nih.gov/36037825
Autor:
Marko Lucijanić, Nevenka Piskač Živković, Marko Zelenika, Mislav Barišić-Jaman, Ivana Jurin, Ana Matijaca, Nikola Zagorec, Marko Lagančić, Besa Osmani, Iva Bušić, Sara Šakota, Ivan Vukoja, Ivica Lukšić, Bruno Baršić
Aim: To assess the long-term survival after hospital discharge of patients hospitalized due to coronavirus disease 2019 (COVID-19). ----- Methods: We retrospectively reviewed data on post-discharge survival of 2586 COVID-19 patients hospitalized in o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a21ed1b9fe605d0647dfd3bdb10a045b
https://urn.nsk.hr/urn:nbn:hr:105:770849
https://urn.nsk.hr/urn:nbn:hr:105:770849
